Physiologic and pharmacologic determinants of vasodilator response: A conceptual framework for rational drug therapy for chronic heart failure
- 28 February 1982
- journal article
- review article
- Published by Elsevier
- Vol. 24 (4) , 275-292
- https://doi.org/10.1016/0033-0620(82)90006-8
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.Circulation, 1980
- Effect of hydralazine on renal failure in patients with congestive heart failure.Circulation, 1980
- Renal effects of nitroprusside and hydralazine in patients with congestive heart failure.Circulation, 1980
- Long-term effects of physical training on coronary patients with impaired ventricular function.Circulation, 1979
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- The effects of left ventricular load and contractility on mitral regurgitant orifice size and flow in the dog.Circulation, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation.Circulation, 1976
- Effect of Nitroprusside on Left Ventricular Dynamics in Mitral RegurgitationCirculation, 1974
- The Effects of Intravenous Apresoline (Hydralazine) on Cardiovascular and Renal Function in Patients with and without Congestive Heart FailureCirculation, 1956